Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of IV Antibiotics for Infective Exacerbations in Cystic Fibrosis
NCT01044719Phase 4Unknown
- Sponsor
- Imperial College London
- Start
- Jan 2010
- Primary completion
- Oct 2010
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of tobramycin, ceftazidime, meropenem in cystic fibrosis (CF), sponsored by Imperial College London. Status: unknown.
02
Drugs
tobramycinceftazidimemeropenem
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01044719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01044719.